Skip to main content
BNC Korea Co, Ltd logo

BNC Korea Co, Ltd — Investor Relations & Filings

Ticker · 256840 ISIN · KR7256840000 KO Manufacturing
Open in API
Filings indexed 283 across all filing types
Latest filing 2024-03-29 Board/Management Inform…
Country KR South Korea
Listing KO 256840

About BNC Korea Co, Ltd

http://www.bnckorea.co.kr

BNC Korea Co., Ltd. is a biomedical company established in 2007 that engages in the research, development, production, and sale of medical devices, pharmaceuticals, and biologicals. The company specializes in products derived from biomaterials, with a particular focus on hyaluronic acid. Its core product portfolio includes hyaluronic acid-based dermal fillers and botulinum toxin injectables for the medical aesthetics market. BNC Korea operates a GMP-certified facility for manufacturing cutting-edge drug substances and specialty medicines, aiming to develop strategic application products for next-generation bio markets.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details specific changes to the company's board of directors, including the appointment of a new outside director and the resignation of an existing one. This falls directly under the category of Board/Management Information (MANG).
2024-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filing from a Korean company. It provides the auditor's opinion (which is 'unqualified' or 'proper'), financial highlights (assets, liabilities, equity, revenue, profit/loss), and details regarding the audit process. While it contains financial data, it is specifically the regulatory announcement of the audit report's submission to the exchange, rather than the full annual report (10-K) or a standalone audit report document. Given the structure and the nature of the disclosure, it fits the 'Audit Report / Information' category. FY 2023
2024-03-21 Korean
투자판단관련주요경영사항 (비에녹스주(보툴리눔독소A형) 국내품목허가)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (한국비엔씨) announcing the approval of a new pharmaceutical product (비에녹스주) by the Ministry of Food and Drug Safety. It follows the standard format for a 'Major Management Matter' (주요경영사항) disclosure, which is a regulatory announcement of a material event. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2024-03-21 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the fiscal year 2023 (2023.01.01 ~ 2023.12.31) submitted by (주)한국비엔씨 to the Financial Services Commission and the Korea Exchange. It contains comprehensive financial information, management discussion, and operational details, which corresponds to the definition of an Annual Report (10-K) in the provided classification system. FY 2023
2024-03-21 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Results of Disposal of Treasury Shares' (자기주식처분결과보고서) filed by BNC Korea. It details the specific number of shares disposed of (80,000 shares), the purpose (employee bonuses), and the resulting change in treasury share holdings. This falls under the category of a company reporting the disposal or transaction of its own shares.
2024-03-11 Korean
불성실공시법인미지정 (지정유예)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory announcement from the Korea Exchange regarding the status of a company (Hankook BNC) as a 'non-designated' entity for unfair disclosure practices. It details the regulatory decision, the grounds for the decision (KOSDAQ disclosure regulations), and the specific penalty points. Since this is a formal regulatory notice regarding compliance and disclosure status that does not fit into specific categories like financial reports or shareholder meetings, it falls under the general regulatory filing category.
2024-03-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.